Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis

Patrick A. Carroll, Daniel Diolaiti, Lisa McFerrin, Haiwei Gu, Danijel Djukovic, Jianhai Du, Pei Feng Cheng, Sarah Anderson, Michelle Ulrich, James B. Hurley, Daniel Raftery, Donald E. Ayer, Robert N. Eisenman

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Deregulated Myc transcriptionally reprograms cell metabolism to promote neoplasia. Here we show that oncogenic Myc requires the Myc superfamily member MondoA, a nutrient-sensing transcription factor, for tumorigenesis. Knockdown of MondoA, or its dimerization partner Mlx, blocks Myc-induced reprogramming of multiple metabolic pathways, resulting in apoptosis. Identification and knockdown of genes coregulated by Myc and MondoA have allowed us to define metabolic functions required by deregulated Myc and demonstrate a critical role for lipid biosynthesis in survival of Myc-driven cancer. Furthermore, overexpression of a subset of Myc and MondoA coregulated genes correlates with poor outcome of patients with diverse cancers. Coregulation of cancer metabolism by Myc and MondoA provides the potential for therapeutics aimed at inhibiting MondoA and its target genes.

Original languageEnglish (US)
Pages (from-to)271-285
Number of pages15
JournalCancer Cell
Volume27
Issue number2
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Carcinogenesis
Neoplasms
Gene Knockdown Techniques
myc Genes
Dimerization
Metabolic Networks and Pathways
Genes
Transcription Factors
Apoptosis
Lipids
Food
Survival
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Carroll, P. A., Diolaiti, D., McFerrin, L., Gu, H., Djukovic, D., Du, J., ... Eisenman, R. N. (2015). Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis. Cancer Cell, 27(2), 271-285. https://doi.org/10.1016/j.ccell.2014.11.024

Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis. / Carroll, Patrick A.; Diolaiti, Daniel; McFerrin, Lisa; Gu, Haiwei; Djukovic, Danijel; Du, Jianhai; Cheng, Pei Feng; Anderson, Sarah; Ulrich, Michelle; Hurley, James B.; Raftery, Daniel; Ayer, Donald E.; Eisenman, Robert N.

In: Cancer Cell, Vol. 27, No. 2, 01.01.2015, p. 271-285.

Research output: Contribution to journalArticle

Carroll, PA, Diolaiti, D, McFerrin, L, Gu, H, Djukovic, D, Du, J, Cheng, PF, Anderson, S, Ulrich, M, Hurley, JB, Raftery, D, Ayer, DE & Eisenman, RN 2015, 'Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis', Cancer Cell, vol. 27, no. 2, pp. 271-285. https://doi.org/10.1016/j.ccell.2014.11.024
Carroll, Patrick A. ; Diolaiti, Daniel ; McFerrin, Lisa ; Gu, Haiwei ; Djukovic, Danijel ; Du, Jianhai ; Cheng, Pei Feng ; Anderson, Sarah ; Ulrich, Michelle ; Hurley, James B. ; Raftery, Daniel ; Ayer, Donald E. ; Eisenman, Robert N. / Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis. In: Cancer Cell. 2015 ; Vol. 27, No. 2. pp. 271-285.
@article{7d16b4f66e6345b3a754e7c83b546256,
title = "Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis",
abstract = "Deregulated Myc transcriptionally reprograms cell metabolism to promote neoplasia. Here we show that oncogenic Myc requires the Myc superfamily member MondoA, a nutrient-sensing transcription factor, for tumorigenesis. Knockdown of MondoA, or its dimerization partner Mlx, blocks Myc-induced reprogramming of multiple metabolic pathways, resulting in apoptosis. Identification and knockdown of genes coregulated by Myc and MondoA have allowed us to define metabolic functions required by deregulated Myc and demonstrate a critical role for lipid biosynthesis in survival of Myc-driven cancer. Furthermore, overexpression of a subset of Myc and MondoA coregulated genes correlates with poor outcome of patients with diverse cancers. Coregulation of cancer metabolism by Myc and MondoA provides the potential for therapeutics aimed at inhibiting MondoA and its target genes.",
author = "Carroll, {Patrick A.} and Daniel Diolaiti and Lisa McFerrin and Haiwei Gu and Danijel Djukovic and Jianhai Du and Cheng, {Pei Feng} and Sarah Anderson and Michelle Ulrich and Hurley, {James B.} and Daniel Raftery and Ayer, {Donald E.} and Eisenman, {Robert N.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.ccell.2014.11.024",
language = "English (US)",
volume = "27",
pages = "271--285",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis

AU - Carroll, Patrick A.

AU - Diolaiti, Daniel

AU - McFerrin, Lisa

AU - Gu, Haiwei

AU - Djukovic, Danijel

AU - Du, Jianhai

AU - Cheng, Pei Feng

AU - Anderson, Sarah

AU - Ulrich, Michelle

AU - Hurley, James B.

AU - Raftery, Daniel

AU - Ayer, Donald E.

AU - Eisenman, Robert N.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Deregulated Myc transcriptionally reprograms cell metabolism to promote neoplasia. Here we show that oncogenic Myc requires the Myc superfamily member MondoA, a nutrient-sensing transcription factor, for tumorigenesis. Knockdown of MondoA, or its dimerization partner Mlx, blocks Myc-induced reprogramming of multiple metabolic pathways, resulting in apoptosis. Identification and knockdown of genes coregulated by Myc and MondoA have allowed us to define metabolic functions required by deregulated Myc and demonstrate a critical role for lipid biosynthesis in survival of Myc-driven cancer. Furthermore, overexpression of a subset of Myc and MondoA coregulated genes correlates with poor outcome of patients with diverse cancers. Coregulation of cancer metabolism by Myc and MondoA provides the potential for therapeutics aimed at inhibiting MondoA and its target genes.

AB - Deregulated Myc transcriptionally reprograms cell metabolism to promote neoplasia. Here we show that oncogenic Myc requires the Myc superfamily member MondoA, a nutrient-sensing transcription factor, for tumorigenesis. Knockdown of MondoA, or its dimerization partner Mlx, blocks Myc-induced reprogramming of multiple metabolic pathways, resulting in apoptosis. Identification and knockdown of genes coregulated by Myc and MondoA have allowed us to define metabolic functions required by deregulated Myc and demonstrate a critical role for lipid biosynthesis in survival of Myc-driven cancer. Furthermore, overexpression of a subset of Myc and MondoA coregulated genes correlates with poor outcome of patients with diverse cancers. Coregulation of cancer metabolism by Myc and MondoA provides the potential for therapeutics aimed at inhibiting MondoA and its target genes.

UR - http://www.scopus.com/inward/record.url?scp=84922784813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922784813&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2014.11.024

DO - 10.1016/j.ccell.2014.11.024

M3 - Article

VL - 27

SP - 271

EP - 285

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 2

ER -